The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5m per quarter. This data-driven, fact-based tracker will continually update based on new filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion.

Fourteen companies currently qualify for inclusion, with six based in the United States and eight in Canada. There have been several updates so far this month. We have updated the Canadian list to reflect the FY18-Q1 report for Aurora Cannabis (TSX: ACB) (OTC: ACBFF) and the FY18-Q2 reports for Canopy Growth (TSX: WEED) (OTC: TWMJF) and MedReleaf (TSX: LEAF) (OTC: MEDFF). Aurora Cannabis reported the highest growth, with sales of C$8.25mm increasing 169% from a year ago. Canopy Growth sales grew 107% to C$17.57mm. MedReleaf revenue fell 9% to C$9.82mm.

In the United States, CV Sciences (OTC: CVSI), GrowGeneration (OTC: GRWG) and Terra Tech (OTC: TRTC) have reported their Q3 financials. Terra Tech cannabis-related sales of $8.67mm grew 82% from a year ago. CV Sciences posted 90% growth, with sales from its industrial hemp products hitting $5.59mm. GrowGeneration reported 86% growth, with revenue of $4.03mm.

Visit the Public Cannabis Company Revenue Tracker to see the complete list of qualifying companies.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email